Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  HIV Infection

  Free Subscription


Articles published in J Virol

Retrieve available abstracts of 252 articles:
HTML format
Text format



Single Articles


    April 2017
  1. MILLER CM, Akiyama H, Agosto LM, Emery A, et al
    Virion associated Vpr alleviates a post-integration block to HIV-1 infection of dendritic cells.
    J Virol. 2017 Apr 19. pii: JVI.00051-17. doi: 10.1128/JVI.00051.
    PubMed     Text format     Abstract available


  2. KIGUOYA MW, Mann JK, Chopera D, Gounder K, et al
    Subtype-Specific Differences in Gag-Protease-Driven Replication Capacity are Consistent with Inter-Subtype Differences in HIV-1 Disease Progression.
    J Virol. 2017 Apr 19. pii: JVI.00253-17. doi: 10.1128/JVI.00253.
    PubMed     Text format     Abstract available


  3. DI PILATO M, Mejias-Perez E, Sorzano COS, Esteban M, et al
    Distinct roles of vaccinia virus NF-kB inhibitor proteins A52, B15 and K7 in the immune response.
    J Virol. 2017 Apr 19. pii: JVI.00575-17. doi: 10.1128/JVI.00575.
    PubMed     Text format     Abstract available


  4. REEVES DB, Peterson CW, Kiem HP, Schiffer JT, et al
    Autologous stem-cell transplantation disrupts adaptive immune responses during rebound SHIV viremia.
    J Virol. 2017 Apr 12. pii: JVI.00095-17. doi: 10.1128/JVI.00095.
    PubMed     Text format     Abstract available


  5. RANKOVIC S, Varadarajan J, Ramalho R, Aiken C, et al
    Reverse transcription mechanically initiates HIV-1 capsid disassembly.
    J Virol. 2017 Apr 5. pii: JVI.00289-17. doi: 10.1128/JVI.00289.
    PubMed     Text format     Abstract available


  6. RINGE RP, Ozorowski G, Yasmeen A, Cupo A, et al
    Improving the expression and purification of soluble, recombinant native-like HIV-1 envelope glycoprotein trimers by targeted sequence changes.
    J Virol. 2017 Apr 5. pii: JVI.00264-17. doi: 10.1128/JVI.00264.
    PubMed     Text format     Abstract available


  7. YI F, Guo J, Dabbagh D, Spear M, et al
    Discovery of Novel Small Molecule Inhibitors of LIM Domain Kinase for Inhibiting HIV-1.
    J Virol. 2017 Apr 5. pii: JVI.02418-16. doi: 10.1128/JVI.02418.
    PubMed     Text format     Abstract available


  8. BAIG TT, Feng Y, Chelico L
    Correction for Baig et al., Determinants of Efficient Degradation of APOBEC3 Restriction Factors by HIV-1 Vif.
    J Virol. 2017;91.
    PubMed     Text format    


    March 2017
  9. CHONG H, Xue J, Xiong S, Cong Z, et al
    A Lipopeptide HIV-1/2 Fusion Inhibitor with Highly Potent in vitro, ex vivo and in vivo Antiviral Activity.
    J Virol. 2017 Mar 29. pii: JVI.00288-17. doi: 10.1128/JVI.00288.
    PubMed     Text format     Abstract available


  10. PETERLIN BM, Liu P, Wang X, Cary D, et al
    Hili inhibits HIV replication in activated T cells.
    J Virol. 2017 Mar 22. pii: JVI.00237-17. doi: 10.1128/JVI.00237.
    PubMed     Text format     Abstract available


  11. RICHARD J, Prevost J, von Bredow B, Ding S, et al
    BST-2 Expression Modulates Small CD4 Mimetic Sensitization of HIV-1-infected cells to ADCC.
    J Virol. 2017 Mar 22. pii: JVI.00219-17. doi: 10.1128/JVI.00219.
    PubMed     Text format     Abstract available


  12. YOSHIKAWA R, Takeuchi JS, Yamada E, Nakano Y, et al
    Feline immunodeficiency virus evolutionarily acquires two proteins, Vif and protease, capable of antagonizing feline APOBEC3.
    J Virol. 2017 Mar 22. pii: JVI.00250-17. doi: 10.1128/JVI.00250.
    PubMed     Text format     Abstract available


  13. CUMMINS NW, Sainski-Nguyen AM, Natesampillai S, Aboulnasr F, et al
    Maintenance of the HIV reservoir is antagonized by selective BCL2 inhibition.
    J Virol. 2017 Mar 22. pii: JVI.00012-17. doi: 10.1128/JVI.00012.
    PubMed     Text format     Abstract available


  14. GAO J, Hay TJ, Banfield BW
    The Product of the Herpes Simplex Virus Type 2 UL16 Gene is Critical for the Egress of Capsids from the Nuclei of Infected Cells.
    J Virol. 2017 Mar 8. pii: JVI.00350-17. doi: 10.1128/JVI.00350.
    PubMed     Text format     Abstract available


  15. CHUANG GY, Geng H, Pancera M, Xu K, et al
    Structure-Based Design of a Soluble Prefusion-Closed HIV-1-Env Trimer with Reduced CD4 Affinity and Improved Immunogenicity.
    J Virol. 2017 Mar 8. pii: JVI.02268-16. doi: 10.1128/JVI.02268.
    PubMed     Text format     Abstract available


  16. ZHANG X, Zhou T, Yang J, Lin Y, et al
    Identification of SERINC5-001 as the Predominant Spliced Isoform for HIV-1 Restriction.
    J Virol. 2017 Mar 8. pii: JVI.00137-17. doi: 10.1128/JVI.00137.
    PubMed     Text format     Abstract available


  17. MARNO KM, O'Sullivan E, Jones CE, Diaz-Delfin J, et al
    RNA-associated Early-stage Anti-viral Factor (REAF) is a major component of LV2 restriction.
    J Virol. 2017 Mar 8. pii: JVI.01228-16. doi: 10.1128/JVI.01228.
    PubMed     Text format     Abstract available


  18. HUANG J, Zhu L, Qiu C, Xu X, et al
    MiR-126-5p enhances the inflammatory responses of monocytes to LPS stimulation by suppressing CYLD in chronic HIV-1 infection.
    J Virol. 2017 Mar 1. pii: JVI.02048-16. doi: 10.1128/JVI.02048.
    PubMed     Text format     Abstract available


  19. LIU Y, Pan J, Cai Y, Grigorieff N, et al
    Conformational states of a soluble, uncleaved HIV-1 envelope trimer.
    J Virol. 2017 Mar 1. pii: JVI.00175-17. doi: 10.1128/JVI.00175.
    PubMed     Text format     Abstract available


  20. OPAZO T, Garces A, Tapia D, Barraza F, et al
    Functional evidence of the involvement of the dynein light chain DYNLRB2 in murine leukemia virus infection.
    J Virol. 2017 Mar 1. pii: JVI.00129-17. doi: 10.1128/JVI.00129.
    PubMed     Text format     Abstract available


  21. SMITH SA, Derdeyn CA
    New connections: Cell to cell HIV-1 transmission, resistance to broadly neutralizing antibodies, and an envelope sorting motif.
    J Virol. 2017 Mar 1. pii: JVI.00149-17. doi: 10.1128/JVI.00149.
    PubMed     Text format     Abstract available


  22. STULTZ RD, Cenker JJ, McDonald D
    Imaging HIV-1 Genomic DNA from Entry through Productive Infection.
    J Virol. 2017 Mar 1. pii: JVI.00034-17. doi: 10.1128/JVI.00034.
    PubMed     Text format     Abstract available


  23. KENNEDY EM, Courtney DG, Tsai K, Cullen BR, et al
    Viral Epitranscriptomics.
    J Virol. 2017 Mar 1. pii: JVI.02263-16. doi: 10.1128/JVI.02263.
    PubMed     Text format     Abstract available


  24. YU FH, Huang KJ, Wang CT
    C-terminal HIV-1 transframe p6* tetra-peptide blocks enhanced Gag cleavage incurred by leucine zipper replacement of a deleted p6* domain.
    J Virol. 2017 Mar 1. pii: JVI.00103-17. doi: 10.1128/JVI.00103.
    PubMed     Text format     Abstract available


    February 2017
  25. WANG W, Zhou J, Halambage UD, Jurado KA, et al
    Inhibition of HIV-1 Maturation via Small Molecule Targeting of the Amino-Terminal Domain in the Viral Capsid Protein.
    J Virol. 2017 Feb 15. pii: JVI.02155-16. doi: 10.1128/JVI.02155.
    PubMed     Text format     Abstract available


  26. ZHENG X, Wang X, Tu F, Wang Q, et al
    TRIM25 Is Required for the Antiviral Activity of Zinc-finger Antiviral Protein (ZAP).
    J Virol. 2017 Feb 15. pii: JVI.00088-17. doi: 10.1128/JVI.00088.
    PubMed     Text format     Abstract available


  27. WANG H, Guo H, Su J, Rui Y, et al
    Inhibition of Vpx-mediated SAMHD1 and Vpr-mediated HLTF degradation by selective disruption of viral CRL4 (DCAF1) E3 ubiquitin ligase assembly.
    J Virol. 2017 Feb 15. pii: JVI.00225-17. doi: 10.1128/JVI.00225.
    PubMed     Text format     Abstract available


  28. MARTINEZ DR, Vandergrift N, Douglas AO, McGuire E, et al
    Maternal binding and neutralizing IgG responses targeting the C terminal region of the V3 loop are predictive of reduced peripartum HIV-1 transmission risk.
    J Virol. 2017 Feb 15. pii: JVI.02422-16. doi: 10.1128/JVI.02422.
    PubMed     Text format     Abstract available


  29. PETRAVIC J, Rasmussen TA, Lewin SR, Kent SJ, et al
    Relationship between measures of HIV reactivation and the decline of latent reservoir under latency-reversing agents.
    J Virol. 2017 Feb 15. pii: JVI.02092-16. doi: 10.1128/JVI.02092.
    PubMed     Text format     Abstract available


  30. GO EP, Ding H, Zhang S, Ringe RP, et al
    A glycosylation benchmark profile for HIV-1 envelope glycoprotein production based on eleven Env trimers.
    J Virol. 2017 Feb 15. pii: JVI.02428-16. doi: 10.1128/JVI.02428.
    PubMed     Text format     Abstract available


  31. QUAN Y, Xu H, Han Y, Mesplede T, et al
    JAK-STAT Signaling Pathways and Inhibitors Affect Reversion of Envelope Mutated HIV-1.
    J Virol. 2017 Feb 15. pii: JVI.00075-17. doi: 10.1128/JVI.00075.
    PubMed     Text format     Abstract available


  32. ZURAWSKI G, Shen X, Zurawski S, Tomaras GD, et al
    Superiority in Rhesus Macaques of Targeting HIV-1 Env Gp140 to CD40 Versus LOX-1 in Combination with Replication Competent NYVAC-KC for Induction of Env-Specific Antibody and T Cell Responses.
    J Virol. 2017 Feb 15. pii: JVI.01596-16. doi: 10.1128/JVI.01596.
    PubMed     Text format     Abstract available


  33. GARCIA-ARRIAZA J, Perdiguero B, Heeney JL, Seaman MS, et al
    HIV/AIDS vaccine candidates based on replication-competent recombinant poxvirus NYVAC-C-KC expressing trimeric gp140 and Gag-derived VLPs or lacking the viral molecule B19 that inhibits type I interferon activate relevant HIV-1-specific B and T cell i
    J Virol. 2017 Feb 8. pii: JVI.02182-16. doi: 10.1128/JVI.02182.
    PubMed     Text format     Abstract available


  34. TSAI A, Irrinki A, Kaur J, Cihlar T, et al
    Toll-Like Receptor 7 Agonist GS-9620 Induces HIV Expression and HIV-Specific Immunity in Cells from HIV-Infected Individuals on Suppressive Antiretroviral Therapy.
    J Virol. 2017 Feb 8. pii: JVI.02166-16. doi: 10.1128/JVI.02166.
    PubMed     Text format     Abstract available


  35. YUE FY, Cohen JC, Ho M, Rahman AK, et al
    HIV-specific granzyme B, but not interferon-gamma secreting T Cells are associated with reduced viral reservoirs in early HIV infection.
    J Virol. 2017 Feb 8. pii: JVI.02233-16. doi: 10.1128/JVI.02233.
    PubMed     Text format     Abstract available


  36. LUND JM, Broliden K, Pyra MN, Thomas KK, et al
    Correction for Lund et al., HIV-1-Neutralizing IgA Detected in Genital Secretions of Highly HIV-1-Exposed Seronegative Women on Oral Preexposure Prophylaxis.
    J Virol. 2017;91.
    PubMed     Text format    


  37. NASAR F, Matassov D, Seymour RL, Latham T, et al
    Recombinant Isfahan virus and vesicular stomatitis virus vaccine vectors provide durable, multivalent, single dose protection against lethal alphavirus challenge.
    J Virol. 2017 Feb 1. pii: JVI.01729-16. doi: 10.1128/JVI.01729.
    PubMed     Text format     Abstract available


  38. LI H, Zony C, Chen P, Chen BK, et al
    Reduced potency and incomplete neutralization of broadly neutralizing antibodies against cell-to-cell transmission of HIV-1 with transmitted founder Envs.
    J Virol. 2017 Feb 1. pii: JVI.02425-16. doi: 10.1128/JVI.02425.
    PubMed     Text format     Abstract available


  39. SUGDEN SM, Pham TN, Cohen EA
    HIV-1 Vpu downmodulates ICAM-1 expression resulting in decreased killing of infected CD4+ T cells by NK cells.
    J Virol. 2017 Feb 1. pii: JVI.02442-16. doi: 10.1128/JVI.02442.
    PubMed     Text format     Abstract available


  40. SELHORST P, Combrinck C, Ndabambi N, Ismail SD, et al
    REPLICATION CAPACITY OF VIRUSES FROM ACUTE INFECTION DRIVES HIV-1 DISEASE PROGRESSION.
    J Virol. 2017 Feb 1. pii: JVI.01806-16. doi: 10.1128/JVI.01806.
    PubMed     Text format     Abstract available


  41. CALONGE E, Bermejo M, Diez-Fuertes F, Mangeot I, et al
    Different Expression of Interferon Stimulated Genes in Response to HIV-1 Infection in Dendritic Cells According to Their Maturation State.
    J Virol. 2017 Feb 1. pii: JVI.01379-16. doi: 10.1128/JVI.01379.
    PubMed     Text format     Abstract available


    January 2017
  42. COLOMER-LLUCH M, Serra-Moreno R
    BCA2/RABRING7 Interferes with HIV-1 Proviral Transcription by Enhancing the SUMOylation of IkappaBalpha.
    J Virol. 2017 Jan 25. pii: JVI.02098-16. doi: 10.1128/JVI.02098.
    PubMed     Text format     Abstract available


  43. BRUEL T, Guivel-Benhassine F, Lorin V, Lortat-Jacob H, et al
    Lack of ADCC breadth of human non-neutralizing anti-HIV-1 antibodies.
    J Virol. 2017 Jan 25. pii: JVI.02440-16. doi: 10.1128/JVI.02440.
    PubMed     Text format     Abstract available


  44. ZHENG W, Ling L, Li Z, Wang H, et al
    Conserved interaction of lentiviral Vif molecules with HIV-1 Gag and differential effects of species-specific Vif on virus production.
    J Virol. 2017 Jan 25. pii: JVI.00064-17. doi: 10.1128/JVI.00064.
    PubMed     Text format     Abstract available


  45. WINANS S, Larue RC, Abraham CM, Shkriabai N, et al
    The FACT complex promotes avian leukosis virus DNA integration.
    J Virol. 2017 Jan 25. pii: JVI.00082-17. doi: 10.1128/JVI.00082.
    PubMed     Text format     Abstract available


  46. MUSICH T, Li L, Liu L, Zolla-Pazner S, et al
    Monoclonal Antibodies to V2, V3, the CD4-binding site and gp41 HIV-1 Mediate Phagocytosis in a Dose-dependent Manner.
    J Virol. 2017 Jan 25. pii: JVI.02325-16. doi: 10.1128/JVI.02325.
    PubMed     Text format     Abstract available


  47. PREVOST J, Zoubchenok D, Richard J, Veillette M, et al
    Influence of the Envelope Gp120 Phe 43 Cavity on HIV-1 Sensitivity to ADCC Responses.
    J Virol. 2017 Jan 18. pii: JVI.02452-16. doi: 10.1128/JVI.02452.
    PubMed     Text format     Abstract available


  48. WANG Y, Pan Q, Ding S, Wang Z, et al
    The V3-loop of HIV-1 Env determines viral susceptibility to IFITM3 impairment of viral infectivity.
    J Virol. 2017 Jan 18. pii: JVI.02441-16. doi: 10.1128/JVI.02441.
    PubMed     Text format     Abstract available


  49. RAHMBERG AR, Rajakumar PA, Billingsley JM, Johnson RP, et al
    Dynamic modulation of expression of lentiviral restriction factors in primary CD4+ T cells following SIV infection.
    J Virol. 2017 Jan 18. pii: JVI.02189-16. doi: 10.1128/JVI.02189.
    PubMed     Text format     Abstract available


  50. RIHN SJ, Foster TL, Busnadiego I, Aziz MA, et al
    The Envelope Gene of Transmitted HIV-1 Resists a Late IFNgamma-Induced Block.
    J Virol. 2017 Jan 18. pii: JVI.02254-16. doi: 10.1128/JVI.02254.
    PubMed     Text format     Abstract available


  51. LAHER F, Ranasinghe S, Porichis F, Mewalal N, et al
    HIV controllers exhibit enhanced frequencies of MHC class II tetramer+ Gag-specific CD4+ T cells in chronic clade C HIV-1 infection.
    J Virol. 2017 Jan 11. pii: JVI.02477-16. doi: 10.1128/JVI.02477.
    PubMed     Text format     Abstract available


  52. EMERY A, Zhou S, Pollom E, Swanstrom R, et al
    Characterizing HIV-1 Splicing Using Next Generation Sequencing.
    J Virol. 2017 Jan 11. pii: JVI.02515-16. doi: 10.1128/JVI.02515.
    PubMed     Text format     Abstract available


  53. FLERIN NC, Chen H, Glover TD, Lamothe PA, et al
    TCR Clonotype-specific Differences in Inhibitory Activity of HIV-1 Cytotoxic T Cell Clones is Not Mediated by TCR Alone.
    J Virol. 2017 Jan 11. pii: JVI.02412-16. doi: 10.1128/JVI.02412.
    PubMed     Text format     Abstract available


  54. RODGERS MA, Wilkerson E, Vallari A, McArthur C, et al
    Sensitive next generation sequencing method reveals deep genetic diversity of HIV-1 in the Democratic Republic of the Congo.
    J Virol. 2017 Jan 11. pii: JVI.01841-16. doi: 10.1128/JVI.01841.
    PubMed     Text format     Abstract available


  55. PEREIRA BITTENCOURT PASSAES C, Bruel T, Decalf J, David A, et al
    Ultrasensitive HIV-1 p24 detects single infected cells and differences in reservoir induction by latency-reversal agents.
    J Virol. 2017 Jan 11. pii: JVI.02296-16. doi: 10.1128/JVI.02296.
    PubMed     Text format     Abstract available


  56. MACK K, Starz K, Sauter D, Langer S, et al
    Efficient Vpu-mediated tetherin antagonism by an HIV-1 group O strain.
    J Virol. 2017 Jan 11. pii: JVI.02177-16. doi: 10.1128/JVI.02177.
    PubMed     Text format     Abstract available


  57. HO CK, Raghwani J, Koekkoek S, Liang RH, et al
    Characterization of HCV envelope diversification from acute to chronic infection using SMRT sequencing within a sexually-transmitted hepatitis C virus cluster.
    J Virol. 2017 Jan 11. pii: JVI.02262-16. doi: 10.1128/JVI.02262.
    PubMed     Text format     Abstract available


  58. SCHMIDT F, Liegeois F, Greenwood EJ, LeBreton M, et al
    Phyloepidemiological analysis reveals that viral divergence led to the paucity of SIVmus/gsn/mon infections in wild populations.
    J Virol. 2017 Jan 11. pii: JVI.01884-16. doi: 10.1128/JVI.01884.
    PubMed     Text format     Abstract available


  59. DONAHUE DA, Porrot F, Couespel N, Schwartz O, et al
    SUN2 silencing impairs CD4 T cell proliferation and alters sensitivity to HIV-1 infection independently of Cyclophilin A.
    J Virol. 2017 Jan 11. pii: JVI.02303-16. doi: 10.1128/JVI.02303.
    PubMed     Text format     Abstract available


  60. JACOBS ES, Keating SM, Abdel-Mohsen M, Gibb SL, et al
    Cytokines Elevated in HIV Elite Controllers Reduce HIV Replication in vitro and Modulate HIV Restriction Factor Expression.
    J Virol. 2017 Jan 4. pii: JVI.02051-16. doi: 10.1128/JVI.02051.
    PubMed     Text format     Abstract available


  61. BECKER JT, Sherer NM
    Subcellular localization of HIV-1 gag-pol mRNAs regulates sites of virion assembly.
    J Virol. 2017 Jan 4. pii: JVI.02315-16. doi: 10.1128/JVI.02315.
    PubMed     Text format     Abstract available


    December 2016
  62. OOMS M, Letko M, Simon V
    The structural interface between HIV-1 Vif and human APOBEC3H.
    J Virol. 2016 Dec 28. pii: JVI.02289-16. doi: 10.1128/JVI.02289.
    PubMed     Text format     Abstract available


  63. PACHECO B, Alsahafi N, Debbeche O, Prevost J, et al
    Residues in the gp41 Ectodomain Regulate HIV-1 Envelope Glycoprotein Conformational Transitions Induced by gp120-directed Inhibitors.
    J Virol. 2016 Dec 21. pii: JVI.02219-16. doi: 10.1128/JVI.02219.
    PubMed     Text format     Abstract available


  64. LEE J, Malmberg JL, Wood BA, Hladky S, et al
    Feline immunodeficiency virus cross-species transmission: Implications for emergence of new lentiviral infections.
    J Virol. 2016 Dec 21. pii: JVI.02134-16. doi: 10.1128/JVI.02134.
    PubMed     Text format     Abstract available


  65. BOLDUC JF, Ouellet M, Hany L, Tremblay MJ, et al
    TLR2 ligation enhances HIV-1 replication in activated CCR6+CD4+ T cells by increasing virus entry and establishing a more permissive environment to infection.
    J Virol. 2016 Dec 7. pii: JVI.01402.
    PubMed     Text format     Abstract available


  66. ROCHAT MA, Schlaepfer E, Speck RF
    Promising Role of Toll-Like Receptor 8 Agonist in Concert with Prostratin for Activation of Silent HIV.
    J Virol. 2016 Dec 7. pii: JVI.02084.
    PubMed     Text format     Abstract available


  67. ZOUBCHENOK D, Veillette M, Prevost J, Sanders-Buell E, et al
    Histidine 375 Modulates CD4 Binding in HIV-1 CRF01_AE Envelope Glycoproteins.
    J Virol. 2016 Dec 7. pii: JVI.02151.
    PubMed     Text format     Abstract available


  68. DIETRICH MH, Ogden KM, Katen SP, Reiss K, et al
    Structural Insights into Reovirus sigma1 Interactions with Two Neutralizing Antibodies.
    J Virol. 2016 Dec 7. pii: JVI.01621.
    PubMed     Text format     Abstract available


  69. SHAW JM, Miller-Novak LK, Mohanram V, McKinnon K, et al
    Influence of Plasma Cell Niche Factors on the Recruitment and Maintenance of IRF4hi Plasma Cells and Plasmablasts in Vaccinated, SIV-Infected Rhesus Macaques with Low and High Viremia.
    J Virol. 2016 Dec 7. pii: JVI.01727.
    PubMed     Text format     Abstract available


  70. BEITARI S, Ding S, Pan Q, Finzi A, et al
    The effect of HIV-1 Env on SERINC5 antagonism.
    J Virol. 2016 Dec 7. pii: JVI.02214.
    PubMed     Text format     Abstract available


  71. KASTURI SP, Kozlowski PA, Nakaya HI, Burger MC, et al
    Adjuvanting an SIV vaccine with TLR ligands encapsulated in nanoparticles induces persistent antibody responses and enhanced protection in TRIM5alpha restrictive macaques.
    J Virol. 2016 Dec 7. pii: JVI.01844.
    PubMed     Text format     Abstract available


    November 2016
  72. WETZEL KS, Yi Y, Elliott ST, Romero D, et al
    CXCR6-mediated SIVagmSab Entry into Sabaeus African Green Monkey Lymphocytes Implicates Widespread Use of Non-CCR5 Pathways in Natural Host Infections.
    J Virol. 2016 Nov 30. pii: JVI.01626.
    PubMed     Text format     Abstract available


  73. WANG L, Wang Y, Zhao J, Ren J, et al
    LUBAC modulates LMP1 activation of NFkappaB and IRF7.
    J Virol. 2016 Nov 30. pii: JVI.01138.
    PubMed     Text format     Abstract available


  74. MURAKOSHI H, Koyanagi M, Chikata T, Rahman MA, et al
    Accumulation of Pol mutations selected by HLA-B*52:01-C*12:02 protective haplotype-restricted CTLs causes low plasma viral load due to low viral fitness of mutant viruses.
    J Virol. 2016 Nov 30. pii: JVI.02082.
    PubMed     Text format     Abstract available


  75. YE C, Wang W, Cheng L, Li G, et al
    Glycosyl-phosphatidylinositol (GPI)-anchored anti-HIV scFv efficiently protect CD4 T cells from HIV-1 infection and deletion in hu-PBL mice.
    J Virol. 2016 Nov 23. pii: JVI.01389.
    PubMed     Text format     Abstract available


  76. WANG Y, Mao L, Kankanala J, Wang Z, et al
    Inhibition of Human Cytomegalovirus pUL89 Terminase Subunit Blocks Virus Replication and Genome Cleavage.
    J Virol. 2016 Nov 23. pii: JVI.02152.
    PubMed     Text format     Abstract available


  77. ARA A, Love RP, Follack TB, Ahmed KA, et al
    Mechanism of enhanced HIV restriction by virion coencapsidated cytidine deaminases APOBEC3F and APOBEC3G.
    J Virol. 2016 Nov 23. pii: JVI.02230.
    PubMed     Text format     Abstract available


  78. MADANI N, Princiotto AM, Zhao C, Jahanbakhshsefidi F, et al
    Activation and Inactivation of Primary Human Immunodeficiency Virus (HIV-1) Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
    J Virol. 2016 Nov 23. pii: JVI.01880.
    PubMed     Text format     Abstract available


  79. BEHRENS RT, Aligeti M, Pocock GM, Higgins CA, et al
    NES masking regulates HIV-1 Rev trafficking and viral RNA nuclear export.
    J Virol. 2016 Nov 16. pii: JVI.02107.
    PubMed     Text format     Abstract available


  80. LIU X, Happel C, Ziegelbauer JM
    KSHV microRNAs Target GADD45B to Protect Infected Cells from Cell Cycle Arrest and Apoptosis.
    J Virol. 2016 Nov 16. pii: JVI.02045.
    PubMed     Text format     Abstract available


  81. PINCUS SH, Song K, Maresh GA, Hamer DH, et al
    Identification of Human Anti-HIV gp160 Monoclonal Antibodies That Make Effective Immunotoxins.
    J Virol. 2016 Nov 16. pii: JVI.01955.
    PubMed     Text format     Abstract available


  82. WANG L, Eng ET, Law K, Gordon RE, et al
    Visualization of HIV T cell virological synapses and virus-containing compartments by 3D correlative light and electron microscopy.
    J Virol. 2016 Nov 9. pii: JVI.01605.
    PubMed     Text format     Abstract available


  83. BEHRENS AJ, Harvey DJ, Milne E, Cupo A, et al
    Molecular architecture of the cleavage-dependent mannose patch on a soluble HIV-1 envelope glycoprotein trimer.
    J Virol. 2016 Nov 2. pii: JVI.01894.
    PubMed     Text format     Abstract available


    October 2016
  84. WANG GZ, Goff SP
    Transcriptional Silencing of Moloney Murine Leukemia Virus in Human Embryonic Carcinoma Cells.
    J Virol. 2016 Oct 26. pii: JVI.02075.
    PubMed     Text format     Abstract available


  85. TAKAHATA T, Takeda E, Tobiume M, Tokunaga K, et al
    Critical Contribution of Tyr15 in the HIV-1 Integrase (IN) to Facilitate the IN Assembly and Non-enzymatic Function Through the IN Precursor Form with Reverse Transcriptase.
    J Virol. 2016 Oct 19. pii: JVI.02003.
    PubMed     Text format     Abstract available


  86. XIONG S, Borrego P, Ding X, Zhu Y, et al
    A Helical Short-Peptide Fusion Inhibitor with Highly Potent Activities against HIV-1, HIV-2 and Simian Immunodeficiency Virus.
    J Virol. 2016 Oct 19. pii: JVI.01839.
    PubMed     Text format     Abstract available


  87. LI C, Wang HB, Kuang WD, Ren XX, et al
    Naf1 regulates HIV-1 latency by suppressing viral promoter-driven gene expression in primary CD4+ T cells.
    J Virol. 2016 Oct 19. pii: JVI.01830.
    PubMed     Text format     Abstract available


  88. CHEESEMAN HM, Olejniczak NJ, Rogers PM, Evans AB, et al
    Broadly Neutralising Antibodies Display Superior Potential Over Non-Neutralising Antibodies in Preventing HIV-1 infection of Mucosal Tissue.
    J Virol. 2016 Oct 19. pii: JVI.01762.
    PubMed     Text format     Abstract available


  89. SU S, Zhu Y, Ye S, Qi Q, et al
    Creating an artificial tail-anchor as a novel strategy to enhance the potency of peptide-based HIV fusion inhibitors.
    J Virol. 2016 Oct 19. pii: JVI.01445.
    PubMed     Text format     Abstract available


  90. WAKEMAN BS, Izumiya Y, Speck SH
    Identification of novel KSHV Orf50 transcripts: discovery of new RTA isoforms with variable transactivation potential.
    J Virol. 2016 Oct 19. pii: JVI.01434.
    PubMed     Text format     Abstract available


  91. PINCUS SH, Song K, Maresh GA, Frank A, et al
    Design and In Vivo Characterization of Immunoconjugates Targeting HIV gp160.
    J Virol. 2016 Oct 19. pii: JVI.01360.
    PubMed     Text format     Abstract available


  92. COSS KP, Vasiljevic S, Pritchard LK, Krumm SA, et al
    HIV-1 glycan density drives the persistence of the mannose patch within an infected individual.
    J Virol. 2016 Oct 5. pii: JVI.01542.
    PubMed     Text format     Abstract available


  93. JIANG X, Totrov M, Li W, Sampson JM, et al
    Rationally Designed Immunogens Targeting HIV-1 gp120 V1V2 Induce Distinct Conformation-Specific Antibody Responses in Rabbits.
    J Virol. 2016 Oct 5. pii: JVI.01409.
    PubMed     Text format     Abstract available


  94. LI S, Folkvord JM, Rakasz EG, Abdelaal HM, et al
    SIV-producing cells in follicles are partially suppressed by CD8+ cells in vivo.
    J Virol. 2016 Oct 5. pii: JVI.01332.
    PubMed     Text format     Abstract available


    September 2016
  95. WU F, Kirmaier A, White E, Ourmanov I, et al
    TRIM5alpha Resistance Escape Mutations in Capsid are Transferable Between Simian Immunodeficiency Virus Strains.
    J Virol. 2016 Sep 28. pii: JVI.01620.
    PubMed     Text format     Abstract available


  96. CHEN CY, Shingai M, Welbourn S, Martin MA, et al
    Antagonism of BST-2/tetherin is a conserved function of the Env glycoprotein of primary HIV-2 isolates.
    J Virol. 2016 Sep 28. pii: JVI.01451.
    PubMed     Text format     Abstract available


  97. TRAUTZ B, Pierini V, Wombacher R, Stolp B, et al
    Antagonism of the SERINC5 Particle Infectivity Restriction by HIV-1 Nef Involves Counteraction of Virion-associated Pools of the Restriction Factor.
    J Virol. 2016 Sep 28. pii: JVI.01246.
    PubMed     Text format     Abstract available


  98. LACOMBE B, Morel M, Margottin-Goguet F, Ramirez BC, et al
    Specific inhibition of HIV infection by spironolactone in T cells.
    J Virol. 2016 Sep 28. pii: JVI.01722.
    PubMed     Text format     Abstract available


  99. EGGINK D, de Taeye SW, Bontjer I, Klasse PJ, et al
    HIV-1 escape from a peptidic anchor inhibitor by envelope glycoprotein spike stabilization.
    J Virol. 2016 Sep 21. pii: JVI.01616.
    PubMed     Text format     Abstract available


  100. LONGO NS, Sutton MS, Shiakolas AR, Guenaga J, et al
    Multiple antibody lineages in one donor target the glycan-V3 supersite of the HIV-1 envelope glycoprotein and display a preference for quaternary binding.
    J Virol. 2016 Sep 21. pii: JVI.01012.
    PubMed     Text format     Abstract available


  101. ARIAS JF, Colomer-Lluch M, von Bredow B, Greene JM, et al
    Tetherin Antagonism by HIV-1 Group M Nef Proteins.
    J Virol. 2016 Sep 21. pii: JVI.01465.
    PubMed     Text format     Abstract available


  102. LIU L, Wang W, Matz J, Ye C, et al
    Glycosyl Phosphatidylinositol-Anchored Variable Region of Llama Heavy Chain Only Antibody JM4 Efficiently Blocks Both Cell-Free and T Cell-T Cell Transmission of Human Immunodeficiency Virus Type 1.
    J Virol. 2016 Sep 21. pii: JVI.01559.
    PubMed     Text format     Abstract available


  103. DENG J, Mitsuki YY, Shen G, Ray J, et al
    HIV envelope gp120 alters T-cell receptor mobilization in the immunological synapse of uninfected CD4 T cells and augments the T cell activation.
    J Virol. 2016 Sep 14. pii: JVI.01532.
    PubMed     Text format     Abstract available


  104. GU Q, Zhang Z, Ortiz LC, Franco AC, et al
    FIV Vif N-Terminal Residues Selectively Counteract Feline APOBEC3s.
    J Virol. 2016 Sep 14. pii: JVI.01593.
    PubMed     Text format     Abstract available


  105. PINZONE MR, Graf E, Lynch L, McLaughlin B, et al
    Monitoring integration over time supports a role for CTL and ongoing replication as determinants of reservoir size.
    J Virol. 2016 Sep 14. pii: JVI.00242.
    PubMed     Text format     Abstract available


  106. ZOLLA-PAZNER S, Powell R, Yahyaei S, Williams C, et al
    RATIONALLY-DESIGNED VACCINES TARGETING THE V2 REGION OF HIV-1 gp120 INDUCE A FOCUSED, CROSS CLADE-REACTIVE, BIOLOGICALLY FUNCTIONAL ANTIBODY RESPONSE.
    J Virol. 2016 Sep 14. pii: JVI.01403.
    PubMed     Text format     Abstract available


  107. COSTA M, Pollara J, Edwards RW, Seaman M, et al
    Fc receptor mediated activities by Env-specific human mAbs generated from volunteers receiving the DNA prime-protein boost HIV vaccine DP6-001.
    J Virol. 2016 Sep 14. pii: JVI.01458.
    PubMed     Text format     Abstract available


  108. PRENTICE HA, Lu H, Price MA, Kamali A, et al
    Dynamics and Correlates of CD8 T-cell Counts in Africans with Primary Human Immunodeficient Virus Type I (HIV-1) Infection.
    J Virol. 2016 Sep 14. pii: JVI.01467.
    PubMed     Text format     Abstract available


  109. KEATING SM, Heitman JW, Wu S, Deng X, et al
    Magnitude and quality of cytokine and chemokine storm during acute infection distinguish non-progressive and progressive simian immunodeficiency virus infections of nonhuman primates.
    J Virol. 2016 Sep 14. pii: JVI.01061.
    PubMed     Text format     Abstract available


    August 2016
  110. BEGO MG, Cong L, Mack K, Kirchhoff F, et al
    Differential Control of BST2 restriction and Plasmacytoid Dendritic Cell Antiviral Response by Antagonists encoded by HIV-1 Group M and O Strains.
    J Virol. 2016 Aug 31. pii: JVI.01131.
    PubMed     Text format     Abstract available


  111. WIBMER CK, Gorman J, Anthony CS, Mkhize NN, et al
    Structure of an N276-dependent HIV-1 Neutralizing Antibody Targeting a Rare V5 Glycan Hole adjacent to the CD4 Binding Site.
    J Virol. 2016 Aug 31. pii: JVI.01357.
    PubMed     Text format     Abstract available


  112. ZHANG Z, Gu Q, Jaguva Vasudevan AA, Jeyaraj M, et al
    Vif Proteins from Diverse HIV/SIV Lineages have Distinct Binding Sites in A3C.
    J Virol. 2016 Aug 31. pii: JVI.01497.
    PubMed     Text format     Abstract available


  113. EBERHARDT MK, Deshpande A, Fike J, Short R, et al
    Exploitation of IL-10 Signaling Pathways: The Alternate Roles of Viral and Cellular IL-10 in Rhesus Cytomegalovirus Infection.
    J Virol. 2016 Aug 24. pii: JVI.00635.
    PubMed     Text format     Abstract available


  114. LA PORTE A, Cano J, Wu X, Mitra D, et al
    An essential role of INI1/hSNF5 chromatin remodeling protein in HIV-1 post-transcriptional events and Gag/GagPol stability.
    J Virol. 2016 Aug 24. pii: JVI.00323.
    PubMed     Text format     Abstract available


  115. AYALA VI, Trivett MT, Barsov EV, Jain S, et al
    Adoptive Transfer of Engineered Rhesus SIV-Specific CD8+ T Cells Reduces the Number of Transmitted/Founder Viruses Established in Rhesus Macaques.
    J Virol. 2016 Aug 24. pii: JVI.01522.
    PubMed     Text format     Abstract available


  116. LUND JM, Broliden K, Pyra MN, Thomas KK, et al
    HIV-1-neutralizing IgA is detected in genital secretions of highly HIV-1 exposed seronegative women on oral pre-exposure prophylaxis.
    J Virol. 2016 Aug 24. pii: JVI.01482.
    PubMed     Text format     Abstract available


  117. BARRETO-DE-SOUZA V, Arakelyan A, Zicari S, Margolis L, et al
    Monocytes but not lymphocytes carrying HIV-1 on their surface transmit infection to human tissue ex vivo.
    J Virol. 2016 Aug 24. pii: JVI.00742.
    PubMed     Text format     Abstract available


  118. STARLING S, Jolly C
    LFA-1 engagement triggers T cell polarization at the HIV-1 virological synapse.
    J Virol. 2016 Aug 24. pii: JVI.01152.
    PubMed     Text format     Abstract available


  119. LIU B, Zou F, Lu L, Chen C, et al
    CAR-T Cells Guided by the Single-Chain Fv of a Broadly Neutralizing Antibody Specifically and Effectively Eradicate the Reactivated Virus-latently-infected CD4+ T-lymphocytes Isolated from HIV-1-infected Individuals Receiving Suppressive cART.
    J Virol. 2016 Aug 17. pii: JVI.00852.
    PubMed     Text format     Abstract available


  120. DING S, Medjahed H, Prevost J, Coutu M, et al
    Lineage-specific differences in the gp120 Inner Domain Layer 3 of Human and Simian Immunodeficiency Viruses.
    J Virol. 2016 Aug 17. pii: JVI.01215.
    PubMed     Text format     Abstract available


  121. SCHMIEDEL D, Tai J, Levi-Schaffer F, Dovrat S, et al
    Human Herpesvirus 6 downregulates the expression of activating ligands during lytic infection to escape elimination by natural killer cells.
    J Virol. 2016 Aug 17. pii: JVI.01164.
    PubMed     Text format     Abstract available


  122. TRINITE B, Chan CN, Lee CS, Levy DN, et al
    Erratum for Trinite et al., HIV-1 Vpr- and Reverse Transcription-Induced Apoptosis in Resting Peripheral Blood CD4 T Cells and Protection by Common Gamma-Chain Cytokines.
    J Virol. 2016;90:7593.
    PubMed     Text format    


  123. MWIMANZI P, Tietjen I, Miller SC, Shahid A, et al
    A novel acylguanidine-based inhibitor of HIV-1.
    J Virol. 2016 Aug 10. pii: JVI.01107.
    PubMed     Text format     Abstract available


  124. VERKERKE HP, Williams JA, Guttman M, Simonich CA, et al
    Epitope-independent purification of native-like envelope trimers from diverse HIV-1 isolates.
    J Virol. 2016 Aug 10. pii: JVI.01351.
    PubMed     Text format     Abstract available


  125. MANGHERA M, Ferguson-Parry J, Lin R, Douville RN, et al
    NF-kappaB and IRF1 Induce Endogenous Retrovirus-K Expression via Interferon-Stimulated Response Elements in its 5' Long Terminal Repeat.
    J Virol. 2016 Aug 10. pii: JVI.01503.
    PubMed     Text format     Abstract available


  126. LIANG Y, Guttman M, Williams JA, Verkerke H, et al
    Changes in structure and antigenicity of HIV-1 Env trimers resulting from removal of a conserved CD4 binding site-proximal glycan.
    J Virol. 2016 Aug 3. pii: JVI.01116.
    PubMed     Text format     Abstract available


    July 2016
  127. LAMERS SL, Rose R, Maidji E, Agsalda-Garcia M, et al
    HIV DNA is frequently present within pathologic tissues evaluated at autopsy from cART-treated patients with undetectable viral load.
    J Virol. 2016 Jul 27. pii: JVI.00674.
    PubMed     Text format     Abstract available


  128. ROSE R, Lamers SL, Nolan DJ, Maidji E, et al
    HIV maintains an evolving and dispersed population among multiple tissues during suppressive cART with periods of rapid expansion corresponding to the onset of cancer.
    J Virol. 2016 Jul 27. pii: JVI.00684.
    PubMed     Text format     Abstract available


  129. MARTRUS G, Niehrs A, Cornelis R, Rechtien A, et al
    Kinetics of HIV-1 latency reversal quantified on the single cell level using a novel flow-based technique.
    J Virol. 2016 Jul 27. pii: JVI.01448.
    PubMed     Text format     Abstract available


  130. DONIUS LR, Cheng Y, Choi J, Sun ZJ, et al
    Generation of long-lived bone marrow plasma cells secreting antibodies specific for HIV-1 gp41 MPER in the absence of polyreactivity.
    J Virol. 2016 Jul 27. pii: JVI.01089.
    PubMed     Text format     Abstract available


  131. HIMES JE, Ho C, Nguyen Q, Amos JD, et al
    Characterization of anatomically compartmentalized plasma and milk simian immunodeficiency virus variants in chronically infected African green monkeys.
    J Virol. 2016 Jul 27. pii: JVI.00701.
    PubMed     Text format     Abstract available


  132. IYER SS, Gangadhara S, Victor B, Shen X, et al
    Virus-like particles displaying trimeric SIV envelope gp160 enhance the breadth of DNA/MVA SIV vaccine induced antibody responses in rhesus macaques.
    J Virol. 2016 Jul 27. pii: JVI.01163.
    PubMed     Text format     Abstract available


  133. RUCEVIC M, Kourjian G, Boucau J, Blatnik R, et al
    MHC-bound HIV Peptides Identified from Various Cell Types Reveal Common Nested Peptides and Novel T Cell Responses.
    J Virol. 2016 Jul 20. pii: JVI.00599.
    PubMed     Text format     Abstract available


  134. YAN Q, Shen C, Qin J, Li W, et al
    HIV-1 Vpr Inhibits Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication by Inducing MiR-942-5p and Activating NF-kappaB Signaling.
    J Virol. 2016 Jul 20. pii: JVI.00797.
    PubMed     Text format     Abstract available


  135. TOWNSLEY S, Mohamed Z, Guo W, McKenna J, et al
    Induction of heterologous Tier 2 HIV-1 neutralizing and cross-reactive V1/V2-specific antibodies in rabbits by prime-boost immunization.
    J Virol. 2016 Jul 20. pii: JVI.00853.
    PubMed     Text format     Abstract available


  136. INLORA J, Chukkapalli V, Bedi S, Ono A, et al
    The molecular determinants directing HIV-1 Gag assembly to the virus-containing compartments in primary macrophages.
    J Virol. 2016 Jul 20. pii: JVI.01004.
    PubMed     Text format     Abstract available


  137. JIMENEZ E, Ruiz A, Kloverpris HN, Rodriguez-Plata MT, et al
    Non-human TRIM5 variants enhance recognition of HIV-1-infected cells by CD8+ T cells.
    J Virol. 2016 Jul 20. pii: JVI.00819.
    PubMed     Text format     Abstract available


  138. DI SCALA M, Otano I, Gil-Farina I, Vanrell L, et al
    Complementary effects of IL-15 and IFN-alpha induce immunity in HBV transgenic mice.
    J Virol. 2016 Jul 20. pii: JVI.01030.
    PubMed     Text format     Abstract available


  139. GACH JS, Venzon D, Vaccari M, Keele BF, et al
    The relationship between vaccine-induced antibody capture of infectious virus and infection outcomes following low-dose, repeated rectal challenge with SIVmac251.
    J Virol. 2016 Jul 20. pii: JVI.00812.
    PubMed     Text format     Abstract available


  140. LOPKER MJ, Del Prete GQ, Estes JD, Li H, et al
    Derivation and characterization of pathogenic transmitted/founder molecular clones from SIVsmE660 and SIVmac251 following mucosal infection.
    J Virol. 2016 Jul 13. pii: JVI.00718.
    PubMed     Text format     Abstract available


  141. MURGATROYD C, Pirrie L, Tran F, Smith TK, et al
    Structure-activity relationships of the Human Immunodeficiency Virus Type 1 maturation inhibitor PF-46396.
    J Virol. 2016 Jul 6. pii: JVI.01075.
    PubMed     Text format     Abstract available


  142. GRAF T, Fritsch HM, de Medeiros RM, Junqueira DM, et al
    Comprehensive characterization of the HIV-1 molecular epidemiology and demographic history in the Brazilian region most heavily affected by AIDS.
    J Virol. 2016 Jul 6. pii: JVI.00363.
    PubMed     Text format     Abstract available


  143. CHACHAGE M, Pollakis G, Kuffour EO, Haase K, et al
    CD25+FoxP3+ memory CD4 T cells are frequent targets of HIV infection in vivo.
    J Virol. 2016 Jul 6. pii: JVI.00612.
    PubMed     Text format     Abstract available


  144. DING S, Tolbert WD, Prevost J, Pacheco B, et al
    A Highly Conserved gp120 Inner Domain Residue Modulates Env Conformation and Trimer Stability.
    J Virol. 2016 Jul 6. pii: JVI.01068.
    PubMed     Text format     Abstract available


    June 2016
  145. MARTIN JL, Cao S, Maldonado JO, Zhang W, et al
    Distinct particle morphologies revealed through comparative parallel analyses of retrovirus-like particles.
    J Virol. 2016 Jun 29. pii: JVI.00666.
    PubMed     Text format     Abstract available


  146. MURRELL B, Vollbrecht T, Guatelli J, Wertheim JO, et al
    The Evolutionary Histories of Antiretroviral Proteins SERINC3 and SERINC5 Do Not Support an Evolutionary Arms Race in Primates.
    J Virol. 2016 Jun 29. pii: JVI.00972.
    PubMed     Text format     Abstract available


  147. ZERBATO JM, Serrao E, Lenzi G, Kim B, et al
    Establishment and Reversal of HIV-1 Latency in Naive and Central Memory CD4+ T Cells in Vitro.
    J Virol. 2016 Jun 29. pii: JVI.00553.
    PubMed     Text format     Abstract available


  148. DAGENAIS-LUSSIER X, Aounallah M, Mehraj V, El-Far M, et al
    Kynurenine Reduces Memory CD4 T-cell Survival by Interfering with IL-2 Signaling early During HIV-1 Infection.
    J Virol. 2016 Jun 29. pii: JVI.00994.
    PubMed     Text format     Abstract available


  149. CHRISTENSEN-QUICK A, Lafferty M, Sun L, Marchionni L, et al
    Human Th17 cells lack HIV-inhibitory RNases and are highly permissive to productive HIV infection.
    J Virol. 2016 Jun 22. pii: JVI.02869.
    PubMed     Text format     Abstract available


  150. GARDNER MR, Fellinger CH, Prasad NR, Zhou AS, et al
    CD4-induced antibodies promote association of the HIV-1 envelope glycoprotein with CD4-binding site antibodies.
    J Virol. 2016 Jun 22. pii: JVI.00803.
    PubMed     Text format     Abstract available


  151. DUTARTRE H, Claviere M, Journo C, Mahieux R, et al
    Cell-free versus cell-to-cell infection by HIV-1 and HTLV-1: exploring the link among viral source, viral trafficking and viral replication.
    J Virol. 2016 Jun 22. pii: JVI.00407.
    PubMed     Text format     Abstract available


  152. DINAPOLI SR, Hirsch VM, Brenchley JM
    Macrophages in progressive HIV/SIV infections.
    J Virol. 2016 Jun 15. pii: JVI.00672.
    PubMed     Text format     Abstract available


  153. YUAN Z, Kang G, Ma F, Lu W, et al
    Recapitulating Cross-Species Transmission of SIVcpz to Humans Using Humanized-BLT Mice.
    J Virol. 2016 Jun 15. pii: JVI.00860.
    PubMed     Text format     Abstract available


  154. SAITO A, Henning MS, Serrao E, Dubose BN, et al
    The capsid-CPSF6 interaction is dispensable for HIV-1 replication in primary cells but is selected during virus passage in vivo.
    J Virol. 2016 Jun 15. pii: JVI.00019.
    PubMed     Text format     Abstract available


  155. TRAN EE, Nelson EA, Bonagiri P, Simmons JA, et al
    Mapping of Ebolavirus Neutralization by Monoclonal Antibodies in the ZMapp Cocktail Using Cryo-Electron Tomography and Studies of Cellular Entry.
    J Virol. 2016 Jun 8. pii: JVI.00406.
    PubMed     Text format     Abstract available


  156. SCHOMMERS P, Martrus G, Matschl U, Sirignano M, et al
    Changes in HIV-1 Capsid stability induced by common CTL-driven viral sequence mutations.
    J Virol. 2016 Jun 8. pii: JVI.00867.
    PubMed     Text format     Abstract available


  157. CALASCIBETTA F, Micci L, Carnathan D, Lawson B, et al
    Antiretroviral therapy in SIV-infected sooty mangabeys: implications for AIDS pathogenesis.
    J Virol. 2016 Jun 8. pii: JVI.00598.
    PubMed     Text format     Abstract available


  158. BULLI L, Apolonia L, Kutzner J, Pollpeter D, et al
    Complex interplay between HIV-1 Capsid and MX2-independent IFNalpha-induced antiviral factors.
    J Virol. 2016 Jun 8. pii: JVI.00458.
    PubMed     Text format     Abstract available


  159. JENSEN K, Nabi R, Van Rompay KK, Robichaux S, et al
    Vaccine-elicited mucosal and systemic antibody responses are associated with reduced simian immunodeficiency viremia in infant rhesus macaques.
    J Virol. 2016 Jun 1. pii: JVI.00481.
    PubMed     Text format     Abstract available


    May 2016
  160. ZHOU S, Bednar MM, Sturdevant CB, Hauser BM, et al
    Deep Sequencing of the HIV-1 env Gene Reveals Discrete X4 Lineages and Linkage Disequilibrium Between X4 and R5 Viruses In the V1/V2 and V3 Variable Regions.
    J Virol. 2016 May 25. pii: JVI.00441.
    PubMed     Text format     Abstract available


  161. GADHAMSETTY S, Coorens T, de Boer RJ
    Notwithstanding circumstantial alibis, cytotoxic T cells can be major killers of HIV-1 infected cells.
    J Virol. 2016 May 25. pii: JVI.00306.
    PubMed     Text format     Abstract available


  162. ALI A, Kitchen SG, Chen IS, Ng HL, et al
    HIV-1-Specific Chimeric Antigen Receptors Based on Broadly-Neutralizing Antibodies.
    J Virol. 2016 May 25. pii: JVI.00805.
    PubMed     Text format     Abstract available


  163. VERMA A, Rajagopalan P, Lotke R, Varghese R, et al
    Functional incompatibility between the generic NF-kappaB motif and a subtype-specific Sp1III element drives the formation of HIV-1 subtype C viral promoter.
    J Virol. 2016 May 18. pii: JVI.00308.
    PubMed     Text format     Abstract available


  164. GARCIA-MIRANDA P, Becker JT, Benner BE, Blume A, et al
    HIV frameshift site RNA stability correlates with frameshift efficiency and decreased viral infectivity.
    J Virol. 2016 May 18. pii: JVI.00149.
    PubMed     Text format     Abstract available


  165. KOOFHETHILE CK, Ndhlovu ZM, Thobakgale-Tshabalala C, Prado JG, et al
    CD8+ T cell breadth and ex vivo virus inhibition capacity distinguish between viremic controllers with and without protective HLA class I alleles.
    J Virol. 2016 May 18. pii: JVI.00276.
    PubMed     Text format     Abstract available


  166. BAILEY AL, Lauck M, Ghai RR, Nelson CW, et al
    Arteriviruses, pegiviruses, and lentiviruses are common among wild African monkeys.
    J Virol. 2016 May 11. pii: JVI.00573.
    PubMed     Text format     Abstract available


  167. PUJOL FM, Laketa V, Schmidt F, Mukenhirn M, et al
    HIV-1 Vpu Antagonizes CD317/tetherin by Adaptor protein-1-Mediated Exclusion from Virus Assembly Sites.
    J Virol. 2016 May 11. pii: JVI.00504.
    PubMed     Text format     Abstract available


  168. CARTWRIGHT EK, Palesch D, Mavigner M, Paiardini M, et al
    Initiation of antiretroviral therapy restores CD4+ TSCM homeostasis in SIV-infected macaques.
    J Virol. 2016 May 11. pii: JVI.00492.
    PubMed     Text format     Abstract available


  169. GARDINER JC, Mauer EJ, Sherer NM
    HIV-1 Gag, Envelope, and extracellular determinants cooperate to regulate the stability and turnover of virological synapses.
    J Virol. 2016 May 11. pii: JVI.00600.
    PubMed     Text format     Abstract available


    April 2016
  170. CUNYAT F, Rainho JN, West B, Swainson L, et al
    CSF-1R antagonists sensitize HIV-1-infected macrophages to TRAIL-mediated killing.
    J Virol. 2016 Apr 27. pii: JVI.00231.
    PubMed     Text format     Abstract available


  171. ISEDA S, Takahashi N, Poplimont H, Nomura T, et al
    Biphasic CD8+ T-cell defense in simian immunodeficiency virus control by acute-phase passive neutralizing antibody immunization.
    J Virol. 2016 Apr 27. pii: JVI.00557.
    PubMed     Text format     Abstract available


  172. RIFE BD, Nolan DJ, Lamers SL, Autissier P, et al
    Evolution of Neuroadaptation in the Periphery and Purifying Selection in the Brain Contribute to Compartmentalization of Simian Immunodeficiency Virus (SIV) in the Brain of Rhesus Macaques with SIV-Associated Encephalitis.
    J Virol. 2016 Apr 27. pii: JVI.00137.
    PubMed     Text format     Abstract available


  173. NOEL N, Pena R, David A, Avettand-Fenoel V, et al
    Long-term Spontaneous control of HIV-1 relates to low frequency of infected cells and inefficient viral reactivation.
    J Virol. 2016 Apr 27. pii: JVI.00419.
    PubMed     Text format     Abstract available


  174. VON BREDOW B, Arias JF, Heyer LN, Moldt B, et al
    Comparison of Antibody-Dependent Cell-Mediated Cytotoxicity and Virus Neutralization by HIV-1 Env-specific Monoclonal Antibodies.
    J Virol. 2016 Apr 27. pii: JVI.00347.
    PubMed     Text format     Abstract available


  175. RHEE SY, Sankaran K, Varghese V, Winters M, et al
    HIV-1 Protease, Reverse Transcriptase, and Integrase Variation.
    J Virol. 2016 Apr 20. pii: JVI.00495.
    PubMed     Text format     Abstract available


  176. LAVENDER KJ, Gibbert K, Peterson KE, Van Dis E, et al
    Interferon alpha Subtype-specific Suppression of HIV-1 Infection in vivo.
    J Virol. 2016 Apr 20. pii: JVI.00451.
    PubMed     Text format     Abstract available


  177. SAITO A, Ferhadian D, Sowd GA, Serrao E, et al
    Roles of capsid-interacting host factors in multimodal inhibition of HIV-1 by PF74.
    J Virol. 2016 Apr 13. pii: JVI.03116.
    PubMed     Text format     Abstract available


  178. KWON YD, Georgiev IS, Ofek G, Zhang B, et al
    Optimization of the Solubility of HIV-1-Neutralizing Antibody 10E8 through Somatic Variation and Structure-Based Design.
    J Virol. 2016 Apr 6. pii: JVI.03246.
    PubMed     Text format     Abstract available


  179. KRISTENSEN AB, Lay WN, Ana-Sosa-Batiz F, Vanderven HA, et al
    Antibody responses with Fc-mediated functions after trivalent influenza vaccination of HIV-infected subjects.
    J Virol. 2016 Apr 6. pii: JVI.00285.
    PubMed     Text format     Abstract available


  180. PLANES R, Ben Haij N, Leghmari K, Serrero M, et al
    HIV-1 Tat protein activates both MyD88 and TRIF pathways to induce TNF-alpha and IL-10 in human monocytes.
    J Virol. 2016 Apr 6. pii: JVI.00262.
    PubMed     Text format     Abstract available


    March 2016
  181. ISHIZAKA A, Sato H, Nakamura H, Koga M, et al
    Short intracellular HIV-1 transcripts as biomarkers of residual immune activation in patients on antiretroviral therapy.
    J Virol. 2016 Mar 30. pii: JVI.03158.
    PubMed     Text format     Abstract available


  182. OU X, Zheng W, Shan Y, Mu Z, et al
    Identification of the Fusion Peptide-Containing Region in Betacoronavirus Spike Glycoproteins.
    J Virol. 2016 Mar 30. pii: JVI.00015.
    PubMed     Text format     Abstract available


  183. AVALOS CR, Price SL, Forsyth ER, Pin JN, et al
    Quantitation of Productively Infected Monocytes and Macrophages of SIV-Infected Macaques.
    J Virol. 2016 Mar 30. pii: JVI.00290.
    PubMed     Text format     Abstract available


  184. ALFADHLI A, Mack A, Ritchie C, Cylinder I, et al
    TRIMER ENHANCEMENT MUTATION EFFECTS ON HIV-1 MATRIX PROTEIN BINDING ACTIVITIES.
    J Virol. 2016 Mar 30. pii: JVI.00509.
    PubMed     Text format     Abstract available


  185. LE GRAND R, Bosquet N, Dispinseri S, Gosse L, et al
    Superior efficacy of an HIV vaccine combined with ARV prevention in SHIV challenged non-human primates.
    J Virol. 2016 Mar 23. pii: JVI.00230.
    PubMed     Text format     Abstract available


  186. HASHEMI FB, Barreto K, Bernhard W, Hashemi P, et al
    HIV provirus stably reproduce parental latent and induced transcription phenotypes regardless of the chromosomal integration site.
    J Virol. 2016 Mar 16. pii: JVI.02842.
    PubMed     Text format     Abstract available


  187. SANCHEZ-MERINO V, Fabra-Garcia A, Gonzalez N, Nicolas D, et al
    Detection of Broadly Neutralizing Activity Within the First Months of HIV-1 Infection.
    J Virol. 2016 Mar 16. pii: JVI.00049.
    PubMed     Text format     Abstract available


  188. RUJAS E, Gulzar N, Morante K, Tsumoto K, et al
    Reply to "The Broadly Neutralizing, Anti-HIV Antibody 4E10: an Open and Shut Case?".
    J Virol. 2016;90:3276-7.
    PubMed     Text format    


  189. STRONG RK, Finton KA
    The Broadly Neutralizing, Anti-HIV Antibody 4E10: an Open and Shut Case?
    J Virol. 2016;90:3274-5.
    PubMed     Text format    


  190. QUERCIOLI V, Primio CD, Casini A, Mulder LC, et al
    COMPARATIVE ANALYSIS OF HIV-1 AND MLV 3D NUCLEAR DISTRIBUTION.
    J Virol. 2016 Mar 9. pii: JVI.03188.
    PubMed     Text format     Abstract available


  191. MADANI N, Princiotto AM, Easterhoff D, Bradley T, et al
    Antibodies Elicited by Multiple Envelope Glycoprotein Immunogens in Primates Neutralize Primary Human Immunodeficiency Viruses (HIV-1) Sensitized by CD4-Mimetic Compounds.
    J Virol. 2016 Mar 9. pii: JVI.03211.
    PubMed     Text format     Abstract available


  192. SUTTON MS, Burns CM, Weiler AM, Balgeman AJ, et al
    Vaccination with live attenuated SIV protects from mucosal, but not necessarily intravenous, challenge with a minimally heterologous SIV.
    J Virol. 2016 Mar 9. pii: JVI.00192.
    PubMed     Text format     Abstract available


  193. HENSLEY-MCBAIN T, Zevin AS, Manuzak J, Smith E, et al
    The effects of fecal microbial transplantation on microbiome and immunity in SIV-infected macaques.
    J Virol. 2016 Mar 2. pii: JVI.00099.
    PubMed     Text format     Abstract available


  194. SWANSTROM AE, Haggarty B, Jordan AP, Romano J, et al
    Derivation and characterization of a CD4-independent, non-CD4 tropic simian immunodeficiency virus.
    J Virol. 2016 Mar 2. pii: JVI.02851.
    PubMed     Text format     Abstract available


  195. KUMAR V, Torben W, Kenway CS, Schiro FR, et al
    Longitudinal examination of the intestinal lamina propria cellular compartment of SIV-infected rhesus macaques provides broader and deeper insights into the link between aberrant microRNA expression and persistent immune activation.
    J Virol. 2016 Mar 2. pii: JVI.00189.
    PubMed     Text format     Abstract available


  196. NELSON CS, Pollara J, Kunz EL, Jeffries TL Jr, et al
    Combined HIV-1 Envelope Systemic and Mucosal Immunization of Lactating Rhesus Monkeys Induces Robust IgA-Isotype B Cell Response in Breast Milk.
    J Virol. 2016 Mar 2. pii: JVI.00335.
    PubMed     Text format     Abstract available


    February 2016
  197. NOMAGUCHI M, Doi N, Sakai Y, Ode H, et al
    Natural single-nucleotide variations in the HIV-1 genomic SA1prox region can alter viral replication ability by regulating Vif expression levels.
    J Virol. 2016 Feb 24. pii: JVI.02939.
    PubMed     Text format     Abstract available


  198. SUNSHINE S, Kirchner R, Amr SS, Mansur L, et al
    HIV Integration Site Analysis of Cellular Models of HIV Latency with a Probe-Enriched Next-Generation Sequencing Assay.
    J Virol. 2016 Feb 24. pii: JVI.01617.
    PubMed     Text format     Abstract available


  199. KRISKO JF, Begum N, Baker CE, Foster JL, et al
    APOBEC3G and APOBEC3F act in Concert to Extinguish HIV-1 Replication.
    J Virol. 2016 Feb 24. pii: JVI.03275.
    PubMed     Text format     Abstract available


  200. VINTON C, Wu F, Rossjohn J, Matsuda K, et al
    MAIT cells are systemically depleted in SIV-infected rhesus macaques.
    J Virol. 2016 Feb 24. pii: JVI.02876.
    PubMed     Text format     Abstract available


  201. BARROS M, Heinrich F, Datta SA, Rein A, et al
    Membrane Binding of HIV-1 MA Protein: Dependence on Bilayer Composition and Protein Lipidation.
    J Virol. 2016 Feb 24. pii: JVI.02820.
    PubMed     Text format     Abstract available


  202. KAPLAN G, Roitburd-Berman A, Lewis GK, Gershoni JM, et al
    The range of CD4-bound conformations of HIV-1 gp120, as defined using conditional CD4-induced antibodies.
    J Virol. 2016 Feb 17. pii: JVI.03206.
    PubMed     Text format     Abstract available


  203. OFFERSEN R, Nissen SK, Rasmussen T, Ostergaard L, et al
    A novel toll-like receptor-9 agonist, MGN1703, enhances HIV-1 transcription and NK cell-mediated inhibition of HIV-1 infected autologous CD4+ T cells.
    J Virol. 2016 Feb 17. pii: JVI.00222.
    PubMed     Text format     Abstract available


  204. ASBACH B, Kliche A, Kostler J, Perdiguero B, et al
    Streamlining Heterologous DNA-Prime and NYVAC/Protein-Boost HIV Vaccine Regimens in Rhesus Macaques by Employing Improved Antigens.
    J Virol. 2016 Feb 10. pii: JVI.03135.
    PubMed     Text format     Abstract available


  205. DONAHUE DA, Amraoui S, di Nunzio F, Kieffer C, et al
    SUN2 overexpression deforms nuclear shape and inhibits HIV.
    J Virol. 2016 Feb 10. pii: JVI.03202.
    PubMed     Text format     Abstract available


  206. MA ZM, Dutra J, Fritts L, Miller CJ, et al
    Lymphatic Dissemination of SIV after Penile Inoculation.
    J Virol. 2016 Feb 10. pii: JVI.02947.
    PubMed     Text format     Abstract available


  207. CUMMINS NW, Sainski AM, Dai H, Natesampillai S, et al
    Prime, shock, and kill: Priming CD4 T cells from HIV patients with a BCL-2 antagonist before HIV reactivation reduces HIV reservoir size.
    J Virol. 2016 Feb 3. pii: JVI.03179.
    PubMed     Text format     Abstract available


  208. JIA M, Lu H, Markowitz M, Cheng-Mayer C, et al
    Development of broadly neutralizing antibodies and their mapping by monomeric gp120 in HIV-1 infected humans and SHIVSF162P3N infected macaques.
    J Virol. 2016 Feb 3. pii: JVI.02898.
    PubMed     Text format     Abstract available


  209. ELLER MA, Goonetilleke N, Tassaneetrithep B, Eller LA, et al
    Expansion of inefficient HIV-specific CD8+ T cells during acute infection.
    J Virol. 2016 Feb 3. pii: JVI.02785.
    PubMed     Text format     Abstract available


  210. GIANELLA S, Anderson C, Var SR, Oliveira MF, et al
    Replication of Human Herpes Viruses is Associated with Greater HIV DNA Levels during Antiretroviral Therapy Started during Early HIV Infection.
    J Virol. 2016 Feb 3. pii: JVI.02638.
    PubMed     Text format     Abstract available


    January 2016
  211. PATIL S, Kumar R, Deshpande S, Samal S, et al
    Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C Infected Elite Neutralizer Mediate Autologous Virus Escape through Mutations in V1 Loop.
    J Virol. 2016 Jan 13. pii: JVI.03090.
    PubMed     Text format     Abstract available


    December 2015
  212. ALSAHAFI N, Ding S, Richard J, Markle T, et al
    Nef proteins from HIV-1 elite controllers are inefficient at preventing ADCC.
    J Virol. 2015 Dec 30. pii: JVI.02973.
    PubMed     Text format     Abstract available


  213. ERLWEIN O, Sweeney NP, de Leon R, Wills G, et al
    Determination of sequences required for HERV-K transduction and its recognition by foreign retroviral virions.
    J Virol. 2015 Dec 30. pii: JVI.02731.
    PubMed     Text format     Abstract available


  214. CHENG C, Pancera M, Bossert A, Schmidt SD, et al
    Immunogenicity of a Prefusion HIV-1-Envelope Trimer in Complex with a Quaternary-Specific Antibody.
    J Virol. 2015 Dec 30. pii: JVI.02380.
    PubMed     Text format     Abstract available


  215. OPP S, Vieira D, Schulte B, Chanda SK, et al
    MxB is not responsible for the block to HIV-1 observed in IFN-alpha-treated cells.
    J Virol. 2015 Dec 30. pii: JVI.03146.
    PubMed     Text format     Abstract available


  216. GUENAGA J, Dubrovskaya V, de Val N, Sharma SK, et al
    Structure-guided redesign increases the propensity of HIV Env to generate highly stable soluble trimers.
    J Virol. 2015 Dec 30. pii: JVI.02652.
    PubMed     Text format     Abstract available


  217. JIANG AP, Jiang JF, Wei JF, Guo MG, et al
    Human mucosal mast cells capture HIV-1 and mediate viral trans-infection of CD4+ T cells.
    J Virol. 2015 Dec 30. pii: JVI.03008.
    PubMed     Text format     Abstract available


  218. GO EP, Cupo A, Ringe R, Pugach P, et al
    Native conformation and canonical disulfide bond formation are interlinked properties of HIV-1 Env glycoproteins.
    J Virol. 2015 Dec 30. pii: JVI.01953.
    PubMed     Text format     Abstract available


  219. URBANOWICZ RA, McClure CP, Brown RJ, Tsoleridis T, et al
    A diverse panel of Hepatitis C Virus glycoproteins for use in vaccine research reveals extremes of monoclonal antibody neutralization resistance.
    J Virol. 2015 Dec 23. pii: JVI.02700.
    PubMed     Text format     Abstract available


  220. CAMPBELL EM, Weingart J, Sette P, Opp S, et al
    TRIM5alpha-mediated ubiquitin chain conjugation is required for inhibition of HIV-1 reverse transcription and capsid destabilization.
    J Virol. 2015 Dec 16. pii: JVI.01948.
    PubMed     Text format     Abstract available


  221. TOKAREV A, Stoneham C, Lewinski MK, Mukim A, et al
    Pharmacologic Inhibition of Nedd8 Activation Enzyme Exposes CD4-induced Epitopes within Env on Cells Expressing HIV-1.
    J Virol. 2015 Dec 16. pii: JVI.02736.
    PubMed     Text format     Abstract available


  222. SMITH SA, Kilgore KM, Kasturi SP, Pulendran B, et al
    Signatures in SIVsmE660 Envelope gp120 are Associated with Mucosal Transmission but not Vaccination Breakthrough in Rhesus Macaques.
    J Virol. 2015 Dec 16. pii: JVI.02711.
    PubMed     Text format     Abstract available


  223. PALLIKKUTH S, Sharkey M, Babic DZ, Gupta S, et al
    Peripheral T Follicular Helper Cells Are the Major HIV Reservoir Within Central Memory CD4 T Cells in Peripheral Blood from chronic HIV infected individuals on cART.
    J Virol. 2015 Dec 16. pii: JVI.02883.
    PubMed     Text format     Abstract available


  224. RANASINGHE S, Soghoian DZ, Lindqvist M, Ghebremichael M, et al
    HIV-1 antibody neutralization breadth is associated with enhanced HIV-specific CD4+ T cell responses.
    J Virol. 2015 Dec 9. pii: JVI.02278.
    PubMed     Text format     Abstract available


  225. RIDDICK NE, Wu F, Matsuda K, Whitted S, et al
    SIVagm efficiently utilizes non-CCR5 entry pathways in African green monkey lymphocytes: Potential role for GPR15 and CXCR6 as Viral Coreceptors.
    J Virol. 2015 Dec 9. pii: JVI.02529.
    PubMed     Text format     Abstract available


  226. DIEFENBACH RJ, Davis A, Miranda Saksena M, Fernandez MA, et al
    The basic domain of HSV-1 pUS9 recruits kinesin-1 to facilitate egress from neurons.
    J Virol. 2015 Dec 9. pii: JVI.03041.
    PubMed     Text format     Abstract available


  227. TANAKA M, Robinson BA, Chutiraka K, Geary CD, et al
    Mutations of conserved residues in the major homology region arrest assembling HIV-1 Gag as a membrane-targeted intermediate containing genomic RNA and cellular proteins.
    J Virol. 2015 Dec 9. pii: JVI.02698.
    PubMed     Text format     Abstract available


  228. LEE WS, Richard J, Lichtfuss M, Smith AB 3rd, et al
    Antibody-dependent cellular cytotoxicity against reactivated HIV-1-infected cells.
    J Virol. 2015 Dec 9. pii: JVI.02717.
    PubMed     Text format     Abstract available


  229. TROTARD M, Tsopoulidis N, Tibroni N, Willemsen J, et al
    Sensing of HIV-1 Infection in Tzm-bl Cells with Reconstituted Expression of STING.
    J Virol. 2015 Dec 9. pii: JVI.02966.
    PubMed     Text format     Abstract available


  230. BANGA R, Procopio F, Cavassini M, Perreau M, et al
    In Vitro Reactivation of Replication Competent and Infectious HIV-1 by HDAC Inhibitors.
    J Virol. 2015 Dec 9. pii: JVI.02359.
    PubMed     Text format     Abstract available


  231. TONGO M, Dorfman JR, Martin DP
    High Degree of HIV-1 group M Genetic Diversity within Circulating Recombinant Forms: Insight into the Early Events of HIV-1M Evolution.
    J Virol. 2015 Dec 9. pii: JVI.02302.
    PubMed     Text format     Abstract available


  232. DING S, Veillette M, Coutu M, Prevost J, et al
    A Highly-Conserved Residue of the HIV-1-gp120 Inner Domain is Important for ADCC Responses Mediated by Anti-Cluster A Antibodies.
    J Virol. 2015 Dec 4. pii: JVI.02779.
    PubMed     Text format     Abstract available


  233. ZHANG Z, Ma J, Zhang X, Su C, et al
    EIAV Gag Assembly and Export are Directed by Matrix Protein through Trans-Golgi Networks and Cellular Vesicles.
    J Virol. 2015 Dec 4. pii: JVI.02814.
    PubMed     Text format     Abstract available


  234. DATTA SA, Clark PK, Fan L, Ma B, et al
    DIMERIZATION OF THE SP-1 REGION OF HIV-1 GAG INDUCES A HELICAL CONFORMATION AND ASSOCIATION INTO HELICAL BUNDLES: IMPLICATIONS FOR PARTICLE ASSEMBLY.
    J Virol. 2015 Dec 4. pii: JVI.02061.
    PubMed     Text format     Abstract available


    November 2015
  235. XU H, Wang X, Malam N, Aye PP, et al
    Persistent SIV infection drives differentiation, aberrant accumulation, and latent infection of germinal center follicular T helper cells.
    J Virol. 2015 Nov 25. pii: JVI.02471.
    PubMed     Text format     Abstract available


  236. FRIIS KP, Iturrioz X, Thomsen J, Alvear-Perez R, et al
    Directed molecular evolution of an engineered gammaretroviral envelope protein with dual receptor use shows stable maintenance of both receptor specificities.
    J Virol. 2015 Nov 25. pii: JVI.02013.
    PubMed     Text format     Abstract available


  237. DAVENPORT YW, West AP Jr, Bjorkman PJ
    Structure of an HIV-2 gp120 in complex with CD4.
    J Virol. 2015 Nov 25. pii: JVI.02678.
    PubMed     Text format     Abstract available


  238. STRAUSS JD, Hammonds JE, Yi H, Ding L, et al
    Three-Dimensional Structural Characterization of HIV-1 Tethered to Human Cells.
    J Virol. 2015 Nov 18. pii: JVI.01880.
    PubMed     Text format     Abstract available


  239. AOKI M, Hayashi H, Yedidi RS, Martyr CD, et al
    The C5-substituted Tetrahydropyrano-tetrahydofuran-derived Protease Inhibitors (PIs) Exert Potent Inhibition of the Replication of HIV-1 Variants Highly Resistant to Various PIs Including Darunavir.
    J Virol. 2015 Nov 18. pii: JVI.01829.
    PubMed     Text format     Abstract available


  240. KEARNEY MF, Wiegand A, Shao W, Coffin JM, et al
    Origin of Rebound Plasma HIV Includes Cells with Identical Proviruses that are Transcriptionally Active Before Stopping Antiretroviral Therapy.
    J Virol. 2015 Nov 18. pii: JVI.02139.
    PubMed     Text format     Abstract available


  241. KHATTAR SK, DeVico AL, LaBranche CC, Panda A, et al
    Enhanced immune responses to HIV-1 envelope elicited by a vaccine regimen consisting of priming with Newcastle disease virus expressing HIV gp160 and boosting with gp120 and SOSIP gp140 proteins.
    J Virol. 2015 Nov 18. pii: JVI.02847.
    PubMed     Text format     Abstract available


  242. BOLTON DL, Pegu A, Wang K, McGinnis K, et al
    HIV-1 monoclonal antibodies suppress acute SHIV viremia and limit seeding of cell-associated viral reservoirs.
    J Virol. 2015 Nov 18. pii: JVI.02454.
    PubMed     Text format     Abstract available


  243. WANG K, Goodman KN, Li DY, Raffeld M, et al
    An Herpes Simplex Virus 2 (HSV-2) gD Mutant Impaired for Neural Tropism is Superior to HSV-2 gD Subunit Vaccine to Protect Animals from Challenge with HSV-2.
    J Virol. 2015 Nov 11. pii: JVI.01845.
    PubMed     Text format     Abstract available


  244. KINLOCH NN, MacMillan DR, Le AQ, Cotton LA, et al
    Population-level Immune-mediated Adaptation in HIV-1 Polymerase during the North American Epidemic.
    J Virol. 2015 Nov 11. pii: JVI.02353.
    PubMed     Text format     Abstract available


  245. BUI JK, Mellors JW, Cillo AR
    HIV-1 virion production from single inducible proviruses following T-cell activation ex vivo.
    J Virol. 2015 Nov 11. pii: JVI.02520.
    PubMed     Text format     Abstract available


  246. PASTERNAK AO, DeMaster LK, Kootstra NA, Reiss P, et al
    Minor Contribution of Host-HIV Readthrough Transcripts to the Level of HIV Cell-associated gag RNA.
    J Virol. 2015 Nov 11. pii: JVI.02597.
    PubMed     Text format     Abstract available


  247. RAUGI DN, Smith RA, Gottlieb GS
    Four Amino Acid Changes in HIV-2 Protease Confer Class-Wide Sensitivity to Protease Inhibitors.
    J Virol. 2015 Nov 11. pii: JVI.01772.
    PubMed     Text format     Abstract available


  248. LU W, Demers AJ, Ma F, Kang G, et al
    RNA-seq Revealed Pyroptosis-induced CD4+ T Cell Death in Early SIV Infected Lymphoid Tissues.
    J Virol. 2015 Nov 11. pii: JVI.02297.
    PubMed     Text format     Abstract available


  249. NAKASHIMA M, Ode H, Kawamura T, Kitamura S, et al
    Structural Insights into HIV-1 Vif-APOBEC3F Interaction.
    J Virol. 2015 Nov 4. pii: JVI.02369.
    PubMed     Text format     Abstract available


  250. DEMASTER LK, Liu X, VanBelzen DJ, Trinite B, et al
    A subset of CD4/CD8 double negative T cells expresses HIV proteins in patients on ART.
    J Virol. 2015 Nov 4. pii: JVI.01913.
    PubMed     Text format     Abstract available


  251. FONTANA J, Keller P, Urano E, Ablan SD, et al
    IDENTIFICATION OF AN HIV-1 MUTATION IN SPACER PEPTIDE 1 THAT STABILIZES THE IMMATURE CA-SP1 LATTICE.
    J Virol. 2015 Nov 4. pii: JVI.02204.
    PubMed     Text format     Abstract available


  252. TRINITE B, Chan CN, Lee CS, Levy DN, et al
    Vpr-dependent and RT-dependent components of HIV-1-induced cell death in resting peripheral blood CD4 T cells, and rescue by common gamma chain cytokines.
    J Virol. 2015 Nov 4. pii: JVI.01770.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: